A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis - Join Clinical Trial NCTNCT06392386
How to Join This Clinical Trial - NCTNCT06392386
Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Generalized Myasthenia Gravis. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Generalized Myasthenia Gravis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Generalized Myasthenia Gravis
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2, PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06392386 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 17 locations. Find a study site near you:
Clinical Research Site
Charlotte, North Carolina 28207 - United States
Status: RECRUITING
Clinical Research Site
Denton, Texas 76208 - United States
Status: RECRUITING
Clinical Research Site
Charlottesville, Virginia 22903 - United States
Status: RECRUITING
Clinical Research Site
Gent, 9000 - Belgium
Status: RECRUITING
Clinical Research Site
Brno, 613 00 - Czechia
Status: RECRUITING
Clinical Research Site
Ostrava, 708 00 - Czechia
Status: RECRUITING
Clinical Research Site
Marseille, 13385 - France
Status: RECRUITING
Clinical Research Site
Essen, 45147 - Germany
Status: RECRUITING
Clinical Research Site
Jerusalem, 9112001 - Israel
Status: RECRUITING
Clinical Research Site
Petah Tikvah, 4920235 - Israel
Status: RECRUITING
And 7 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2, PHASE3 clinical trial for Generalized Myasthenia Gravis:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships